Composition
-
Omeprazole 20 mg (Proton Pump Inhibitor)
-
Levosulpiride 75 mg (Prokinetic & Antipsychotic – low dose used for gastric motility disorders)
Description
Omez L Capsule is a combination medicine used in the treatment of acid reflux, GERD, chronic gastritis, indigestion, and functional dyspepsia.
-
Omeprazole reduces excess stomach acid by blocking proton pumps in the stomach lining.
-
Levosulpiride enhances gastric motility, reduces bloating, and prevents reflux by helping food move faster from the stomach to the intestines.
This dual action provides relief from heartburn, nausea, abdominal discomfort, and acid regurgitation.
Uses
-
Gastroesophageal Reflux Disease (GERD)
-
Chronic acidity and heartburn
-
Functional dyspepsia (indigestion, bloating, belching)
-
Gastritis and peptic ulcers
-
Nausea, vomiting, reflux symptoms
Benefits
-
Dual action: acid suppression + improved digestion
-
Relieves heartburn, bloating, nausea, and indigestion
-
Promotes faster gastric emptying
-
Convenient once-daily dosage (as prescribed)
Dosage
-
Usual adult dose: 1 capsule once daily, preferably before meals
-
Must be taken on doctor’s prescription only
Side Effects
Common:
-
Headache, dizziness
-
Nausea, constipation or diarrhea
-
Abdominal pain, gas
-
Mild sleepiness or restlessness (due to levosulpiride)
Rare (long-term use):
-
Vitamin B12 deficiency (omeprazole)
-
Hormonal imbalance (galactorrhea, menstrual irregularities due to levosulpiride in rare cases)
Precautions
-
Avoid in patients with severe heart, liver, or kidney disease
-
Not recommended during pregnancy & breastfeeding unless prescribed
-
Avoid alcohol and smoking for best results
-
Long-term use only under strict medical supervision
Storage
-
Store in a cool, dry place, away from sunlight & moisture
-
Keep away from children
Packaging
-
Pack size: Strip of 10 capsules
✅ Note: Omez L Capsule should be taken only on a doctor’s advice, especially since levosulpiride has central nervous system effects in addition to gastric benefits.
Reviews
There are no reviews yet.